INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP • US4577301090
60.64 USD
+0.88 (+1.47%)
Last: Feb 17, 2026, 01:02 PM
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year INSP was profitable.
- In the past year INSP had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: INSP reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
- INSP's Return On Assets of 5.52% is amongst the best of the industry. INSP outperforms 82.70% of its industry peers.
- INSP has a Return On Equity of 6.69%. This is in the better half of the industry: INSP outperforms 80.00% of its industry peers.
- With a decent Return On Invested Capital value of 4.82%, INSP is doing good in the industry, outperforming 74.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP's Profit Margin of 5.05% is fine compared to the rest of the industry. INSP outperforms 77.84% of its industry peers.
- With a decent Operating Margin value of 4.16%, INSP is doing good in the industry, outperforming 68.11% of the companies in the same industry.
- INSP has a Gross Margin of 84.92%. This is amongst the best in the industry. INSP outperforms 94.59% of its industry peers.
- In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
- INSP has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for INSP has been increased compared to 5 years ago.
- There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- INSP has an Altman-Z score of 8.84. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
- INSP has a Altman-Z score of 8.84. This is amongst the best in the industry. INSP outperforms 88.65% of its industry peers.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.84 |
ROIC/WACC0.48
WACC9.98%
2.3 Liquidity
- INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- INSP has a Current ratio of 5.29. This is amongst the best in the industry. INSP outperforms 80.54% of its industry peers.
- A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
- INSP has a better Quick ratio (4.01) than 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 45.09% over the past year.
- INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.60%.
- The Revenue has been growing by 51.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
3.2 Future
- Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.46% on average per year.
- INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.27% yearly.
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 24.16, which indicates a rather expensive current valuation of INSP.
- 78.92% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.19, INSP is valued at the same level.
- Based on the Price/Forward Earnings ratio of 34.40, the valuation of INSP can be described as expensive.
- 69.73% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
- INSP is valuated rather expensively when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.16 | ||
| Fwd PE | 34.4 |
4.2 Price Multiples
- INSP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INSP is cheaper than 70.81% of the companies in the same industry.
- INSP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INSP is cheaper than 92.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.83 | ||
| EV/EBITDA | 24.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y11.77%
5. Dividend
5.1 Amount
- No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:INSP (2/17/2026, 1:02:07 PM)
60.64
+0.88 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2026-02-11/amc
Earnings (Next)05-04 2026-05-04/amc
Inst Owners111.59%
Inst Owner Change1.15%
Ins Owners0.74%
Ins Owner Change0.07%
Market Cap1.76B
Revenue(TTM)911.98M
Net Income(TTM)44.56M
Analysts76.8
Price Target131.09 (116.18%)
Short Float %13.43%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.17%
PT rev (3m)3.12%
EPS NQ rev (1m)32.34%
EPS NQ rev (3m)30.73%
EPS NY rev (1m)39.14%
EPS NY rev (3m)185.48%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.16 | ||
| Fwd PE | 34.4 | ||
| P/S | 2 | ||
| P/FCF | 17.83 | ||
| P/OCF | 13.18 | ||
| P/B | 2.64 | ||
| P/tB | 2.64 | ||
| EV/EBITDA | 24.41 |
EPS(TTM)2.51
EY4.14%
EPS(NY)1.76
Fwd EY2.91%
FCF(TTM)3.4
FCFY5.61%
OCF(TTM)4.6
OCFY7.59%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 8.84 |
F-Score8
WACC9.98%
ROIC/WACC0.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year694.28%
EBIT Next 3Y129.9%
EBIT Next 5Y70.54%
FCF growth 1Y158.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.68%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 24.16 and the Price/Book (PB) ratio is 2.64.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 9 / 10.